Axcella long COVID treatment helps some patients in small trial

  • 📰 CTVNews
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 99%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

One of the first trials aimed at tackling long COVID helped some patients recover from lingering physical and mental fatigue, although the drug developed by Axcella Health Inc failed on the small study's main goal of restoring the normal function of mitochondria - the energy factories of cells.

In the 41-patient pilot study released on Tuesday, for three of 21 patients who received the drug, AXA1125, their physical fatigue scores returned to normal levels after 28 days of treatment, Axcella Chief Medical Officer Margaret Koziel said in a phone interview.

The drug, originally developed for fatty liver disease, aims to treat the crushing chronic fatigue reported by more than half of long COVID-19 sufferers by restoring normal function of mitochondria, the minuscule power plants that help cells perform properly. For the study's primary goal, there was no statistically significant difference between the groups on phosphocreatine recovery time.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

No more drugs! Turn to natural remedies to help you! Big pharma does not want what’s best for you, they want to keep you coming back again and again to line their pockets. Wake up people!

Big pharma sure is making a killing

Long covid is a cover-up of vaccines side effects. So the solution is to take another medication that's equally untested and unknown?

Still spreading the lie that there is a deadly pandemic we should be worried about

You know what also helps? Ivrmectin. Been around forever and even pregnant women can take it. Ignoring it is just pathetic and ridiculous

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in HEALTH

Health Health Latest News, Health Health Headlines